Envision Pharma Group
Karen Pemberton PhD CMPP is an experienced scientific professional currently serving as Scientific Director and Account Lead at Envision Pharma Group since May 2015, while also holding the role of Principal Medical Writer. Previous roles include Associate Director of Scientific Strategy at Prime Global for a brief period in 2021 and multiple positions at PAREXEL from January 2010 to May 2015, including Senior Scientific Specialist and Scientific Writer. Karen has academic experience as an Adjunct Faculty member at Manchester Community College, teaching Pharmacology and Pathophysiology, and has worked in competitive intelligence for pharmaceuticals and medical devices at Nerac from June 2005 to July 2009. Additional professional history includes serving as Assistant Scientific Director at MedKnowledge Group and CEO of Thistle Technologies, alongside research positions at Cognetix, Yale University, and the University of Vermont. Educationally, Karen holds a PhD in Physiology and Pharmacology and an MSc in Pharmacology from the University of Strathclyde, as well as a BSc in Physiology from the University of St Andrews.
This person is not in any teams
This person is not in any offices
Envision Pharma Group
1 followers
The Envision Pharma Group is an innovative scientific communications and technology company, focused on the life science industry working with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner.